MM+M editors Marc Iskowitz and Larry Dobrow interview people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes to be released every Wednesday.
The unprecedented nature of the FDA’s approval of Alzheimer’s drug Aduhelm has led to more negative publicity than perhaps any other new medication. Wayne Pines, former FDA official and now president of healthcare at APCO, joins Marc Iskowitz to discuss the implications for the agency’s role in advising pharma companies.
As the short list goes live for this year’s MM+M Awards, Otsuka’s Elaine Gamble, chair of judges, debriefs with MM+M’s Marc Iskowitz about her impressions of working with some of the 80-member jury during last month’s virtual judging, as well as general trends she noticed in the entries.
Tim Frank created Triple Threat Communications more than 15 years ago. Clients soon dubbed it “The Unagency.” So what’s that about, how is it performing, and why might the big network agencies be a bit nervous?”
Weber Shandwick’s Peter Matheson Gay and United Minds’ Tai Wingfield discuss the role organizations can play in driving progress to close health equity gaps.
As COVID-19 vaccination slows in this country, a study finds behavioral nudges may be able to encourage the hesitant to get shots. Jacob Braude, from ZS’s applied behavioral science unit, explains the findings and their commercial applications.
With the debut of the Agency 100 issue today, MM+M’s Marc Iskowitz is joined by Stephen Madden, editor-and-chief/GM, and Larry Dobrow, executive editor, to discuss the digital and print content package and what it took to get it done.
Roni Chase, VP of marketing at Lilly and an economist by training, explains why real world evidence (RWE) deserves to play a bigger role in pharma’s commercial strategy.
As COVID-19 vaccinations roll out and restrictions are lifted, consumers are in a state of transition that impacts mental health in many ways. In this sponsored podcast, therapist and Verywell Editor-in-Chief Amy Morin discusses how attitudes and behaviors are changing, the importance of keeping a finger on the shifts, and how health publishers can better understand and meet consumers’ needs during this long-awaited return to normalcy.
Juice Pharma’s Forrest King and Harrison and Star’s Mario Muredda and Paulette Robinson join Marc Iskowitz for the second of a four-part series exploring how MAHF member agencies are progressing toward diversity, equity and inclusion.
The COVID-19 pandemic has had a major impact on patients’ preferences and expectations when it comes to care, and it’s accelerated the move toward consumerism.
The role of work-life balance in the agency world — especially in communications/PR — is often discussed, but why should clients care and why should they seek out agency partners who place a high value on work-life balance for their own teams?
Pharmaceutical reps, patients and fellow HCPs are trying to get closer to doctors at a time when they’re driven further apart. A Q4 2020 study conducted by MM+M and RFH revealed unexpected truths for marketers that are now being released in the eBook, The Partnership Paradox.
How Splice’s embrace of individual growth and ‘creativity without walls’ underscores the agency’s employee-first culture.
How much of an impact did the pandemic have on medicine spending last year? IQVIA’s Murray Aitken joins MM+M’s Marc Iskowitz to provide a rundown on spend and usage trends, as well as the institute’s outlook for all medicine use through 2025.
Machine learning and artificial intelligence offer an unprecedented opportunity for pharmaceutical marketing to deliver differentiated messaging to precise patient and HCP audiences on the right channels at the right moment in time.
Dr. Charlotte Jones-Burton, WOCIP president and cofounder, discusses the group’s latest initiative, designed to address vaccine hesitancy among the Black and brown communities by training members of the pharma industry to “demystify” and educate on COVID-19 vaccine clinical trial data.
Heathline Media’s Brendan McHenry discusses complementary health and financial wellness as pillars of the company’s Whole Person Health Initiative.
Surveying patients for a new research report, DeepIntent found that nearly three-quarters of patients believe more lives can be saved if people were better informed about their treatment options — and that many patients don’t feel informed.
Lisa Stockman Mauriello and husband Bob Mauriello, who have been leading a high-profile campaign to gain access to Biogen’s tofersen under so-called expanded access, discuss the drugmaker’s decision this week to make the experimental ALS drug available, but not as soon as they had hoped.
Healthline Media’s Kate Gallagher presents the company’s multi-faceted Whole Person Health Initiative program.